Target Name: LOC105374009
NCBI ID: G105374009
Review Report on LOC105374009 Target / Biomarker Content of Review Report on LOC105374009 Target / Biomarker
LOC105374009
Other Name(s): Uncharacterized LOC105374009 | uncharacterized LOC105374009

A closer look at LOC105374009: A Potential Drug Target and Biomarker

LOC105374009 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. This protein is a key component of the cell membrane and is involved in various cellular processes. Its unique structure and function make it an attractive target for drug development. In this article, we will provide a more detailed overview of LOC105374009, including its structure, function, and potential as a drug target and biomarker.

Structure and Function

LOC105374009 is a 21-kDa protein that is composed of two distinct regions: an N-terminal region and a C-terminal region. The N-terminal region is responsible for the protein's cytoplasmic localization, while the C-terminal region is involved in its nuclear localization. The protein has a unique topology, with a long N-terminal region that is involved in protein-protein interactions and a short C-terminal region that is involved in protein-nucleic acid interactions.

LOC105374009 is involved in various cellular processes, including cell signaling, cell adhesion, and cell migration. It is a key regulator of the cytoskeleton and is involved in the assembly and disassembly of microtubules. LOC105374009 has been shown to play a role in the regulation of cell division, cell migration, and the establishment of tissue boundaries.

In addition to its role in cellular processes, LOC105374009 has also been shown to be involved in the regulation of gene expression. Studies have shown that LOC105374009 can interact with various transcription factors, including DNMTAT, p53, and NF-kappa-B. This suggests that LOC105374009 may be involved in the regulation of gene expression and could potentially serve as a drug target.

Potential as a Drug Target

The potential of LOC105374009 as a drug target is based on its unique structure and function. Its N-terminal region allows it to interact with various cytoplasmic proteins, while its C-terminal region allows it to interact with DNA and RNA. This makes it an attractive target for small molecules that can modulate its activity.

One of the promising aspects of LOC105374009 is its role in the regulation of cell division and its involvement in the assembly and disassembly of microtubules. Drugs that can disrupt microtubule assembly or stability have been shown to be effective in various diseases, including cancer. LOC105374009 may also be a useful target for drugs that aim to inhibit its role in cell division and cell signaling.

Another potential mechanism by which LOC105374009 could be targeted is its role in the regulation of gene expression. Drugs that can modulate gene expression have been shown to be effective in various diseases, including cancer. LOC105374009 may be a useful target for drugs that aim to disrupt its interaction with transcription factors and thereby inhibit gene expression.

Potential as a Biomarker

LOC105374009 has also been identified as a potential biomarker for various diseases, including cancer. Its unique structure and function make it an attractive target for diagnostic agents that can detect and monitor its levels in the body.

One of the potential applications of LOC105374009 as a biomarker is its ability to serve as a target for diagnostic agents that

Protein Name: Uncharacterized LOC105374009

The "LOC105374009 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374009 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985